Your browser is no longer supported. Please, upgrade your browser.
Settings
ENDP Endo International plc daily Stock Chart
ENDP [NASD]
Endo International plc
Index- P/E- EPS (ttm)-2.10 Insider Own0.80% Shs Outstand240.45M Perf Week-16.86%
Market Cap841.58M Forward P/E1.49 EPS next Y2.35 Insider Trans-1.78% Shs Float201.97M Perf Month-10.49%
Income-471.00M PEG- EPS next Q0.48 Inst Own97.50% Short Float12.75% Perf Quarter-53.46%
Sales2.97B P/S0.28 EPS this Y24.90% Inst Trans1.70% Short Ratio5.79 Perf Half Y-63.66%
Book/sh-2.20 P/B- EPS next Y7.70% ROA-5.30% Target Price8.65 Perf Year-66.86%
Cash/sh4.08 P/C0.86 EPS next 5Y-13.25% ROE170.90% 52W Range3.48 - 18.50 Perf YTD-52.05%
Dividend- P/FCF15.61 EPS past 5Y-35.50% ROI-5.70% 52W High-81.08% Beta1.17
Dividend %- Quick Ratio1.10 Sales past 5Y6.80% Gross Margin45.40% 52W Low0.57% ATR0.32
Employees2910 Current Ratio1.30 Sales Q/Q2.80% Oper. Margin2.30% RSI (14)29.52 Volatility8.59% 7.86%
OptionableYes Debt/Eq- EPS Q/Q97.50% Profit Margin-18.40% Rel Volume1.71 Prev Close3.50
ShortableYes LT Debt/Eq- EarningsAug 06 BMO Payout- Avg Volume4.45M Price3.50
Recom3.00 SMA20-13.76% SMA50-31.10% SMA200-63.21% Volume0 Change0.00%
Jul-15-19Downgrade Morgan Stanley Equal-Weight → Underweight
Jun-17-19Downgrade Citigroup Buy → Neutral
Jun-11-19Initiated Barclays Equal Weight
May-13-19Downgrade JP Morgan Neutral → Underweight
Mar-20-19Initiated SunTrust Buy
Mar-05-19Downgrade SVB Leerink Outperform → Mkt Perform
Nov-09-18Upgrade Canaccord Genuity Hold → Buy $16 → $20
Sep-11-18Upgrade Goldman Sell → Neutral
Aug-13-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Aug-09-18Reiterated Stifel Hold $10 → $17
Jun-27-18Upgrade Citigroup Neutral → Buy
Apr-04-18Downgrade Mizuho Buy → Neutral $12 → $7
Feb-28-18Downgrade Gabelli & Co Buy → Hold
Feb-14-18Initiated B. Riley FBR, Inc. Buy $10
Jan-03-18Reiterated Mizuho Buy $14 → $12
Jan-03-18Initiated Leerink Partners Outperform $12
Dec-12-17Initiated Guggenheim Neutral $8.50
Nov-10-17Reiterated RBC Capital Mkts Sector Perform $9 → $8
Sep-28-17Initiated Goldman Sell $7
Aug-09-17Reiterated RBC Capital Mkts Sector Perform $15 → $9
Jul-17-19 10:10AM  Can Endo (ENDP) Keep the Earnings Surprise Streak Alive? Zacks -5.15%
07:21AM  3 Drug Stocks With Unimaginably Low P/E Ratios Motley Fool
Jul-16-19 03:16PM  Teva Shares Fall Further as Morgan Stanley Downgrades Rating Zacks -6.58%
Jul-15-19 04:36PM  Teva Pharmaceuticals News: Why TEVA Stock Is Sliding Today InvestorPlace
12:00PM  Teva Relief Rally Loses Steam After Analyst Downgrade Investopedia
10:35AM  Morgan Stanley Downgrades Teva, Endo On Drug Pricing And Litigation Concerns Benzinga
10:19AM  Teva and Endo Stock Are Falling Because Opioid Suits Arent Going Away Barrons.com
Jul-11-19 05:00PM  Endo to Announce Second-Quarter 2019 Financial Results CNW Group -5.94%
Jul-01-19 03:48PM  Why Endo International Stock Is Jumping Today Motley Fool +11.41%
02:45PM  Endo International Jumps 12% After Taking a $300 Million Loan Barrons.com
01:13PM  Endo Luxembourg Finance I Company S.a.r.l. -- Moody's downgrades Endo's CFR to B3; outlook revised to stable Moody's
Jun-25-19 10:18AM  AbbVies $63 Billion Allergan Deal Gives Life to Industry Bloomberg
07:42AM  Drug maker stocks rally after AbbVie's deal to buy Allergan for 45% premium MarketWatch
Jun-21-19 08:59AM  Is Endo International plc's (NASDAQ:ENDP) CEO Pay Fair? Simply Wall St.
08:58AM  How Should Investors Feel About Endo International plc's (NASDAQ:ENDP) CEO Pay? Simply Wall St.
08:44AM  Options Traders Expect Huge Moves in Endo (ENDP) Stock Zacks
Jun-19-19 09:08PM  Heres What Hedge Funds Think About Endo International plc (ENDP) Insider Monkey
Jun-18-19 08:00AM  Nevakar Enters $50 Million Product Financing Agreement with NovaQuest Capital for Continued Development of Injectable Products GlobeNewswire
Jun-08-19 09:30AM  Why Is Endo (ENDP) Down 38.9% Since Last Earnings Report? Zacks
Jun-06-19 07:30AM  Nationally Recognized Urologist and Author, Aaron Spitz, MD, Teams Up with Endo Pharmaceuticals' Ask About the Curve Campaign to Encourage Men to Get "In Touch" With Their Anatomy This Men's Health Month PR Newswire
07:30AM  Nationally Recognized Urologist and Author, Aaron Spitz, MD, Teams Up with Endo Pharmaceuticals' Ask About the Curve Campaign to Encourage Men to Get "In Touch" With Their Anatomy This Men's Health Month CNW Group
May-23-19 12:07PM  This May Hurt a Little (Or a Lot) as Opioids Haunt Pharma Bonds Bloomberg
May-22-19 05:55PM  Larry Robbins' Top 6 Buys of the 1st Quarter GuruFocus.com
May-17-19 07:00AM  Phase 3 Data of Collagenase Clostridium Histolyticum for the Investigational Treatment of Cellulite to Be Presented at The Aesthetic Meeting 2019 CNW Group
May-16-19 10:56AM  Introducing Endo International (NASDAQ:ENDP), The Stock That Tanked 91% Simply Wall St.
May-15-19 05:00PM  Endo to Participate at RBC Healthcare Conference PR Newswire
12:55AM  Edited Transcript of ENDP earnings conference call or presentation 9-May-19 11:30am GMT Thomson Reuters StreetEvents
May-14-19 04:00PM  There's misinformation out there on generic drugs: Association of Accessible Medicines CEO CNBC Videos
May-13-19 11:42AM  Why Endo International Shares Are Under Pressure Today Motley Fool -19.23%
May-10-19 02:41PM  Endo (ENDP) Q1 Earnings & Revenues Beat Estimates Zacks
02:24PM  Endo International (ENDP) Q1 2019 Earnings Call Transcript Motley Fool
May-09-19 08:05AM  Endo International (ENDP) Beats Q1 Earnings and Revenue Estimates Zacks
07:46AM  Endo: 1Q Earnings Snapshot Associated Press
07:06AM  Drugmaker Endo posts narrower first-quarter loss Reuters
06:58AM  Drugmaker Endo quarterly results beat on robust sales of Xiaflex Reuters
06:30AM  Endo Reports First-Quarter 2019 Financial Results CNW Group
May-07-19 09:40AM  BioDelivery (BDSI) Stock Up on Q1 Earnings and Sales Beat Zacks
May-03-19 09:51AM  What's in Store for Catalyst Pharma (CPRX) Q1 Earnings? Zacks +6.22%
May-02-19 12:41PM  Is Endo International plc (ENDP) A Good Stock To Buy ? Insider Monkey
10:32AM  Analysts Estimate Endo International (ENDP) to Report a Decline in Earnings: What to Look Out for Zacks
10:11AM  What's in Store for BioDelivery (BDSI) This Earnings Season? Zacks
May-01-19 05:35PM  Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall of One Lot of Mycophenolate Mofetil for Injection, USP Due to the Presence of a Glass Fragment Observed in One Vial of Reconstituted Product CNW Group
Apr-30-19 08:02AM  What's in Store for BioSpecifics (BSTC) This Earnings Season? Zacks
Apr-10-19 05:00PM  Endo to Announce First-Quarter 2019 Financial Results PR Newswire
Apr-09-19 02:04PM  When Will Endo International plc (NASDAQ:ENDP) Breakeven? Simply Wall St.
Apr-05-19 07:30AM  Endo Begins Shipment of Authorized Generic Version of PROVENTIL® (albuterol sulfate) HFA Inhalation Aerosol in the United States PR Newswire
Apr-01-19 12:38PM  Drug companies that benefit from the war on opioid addiction Yahoo Finance
11:16AM  Drug companies that benefit from the war on opioid addiction Yahoo Finance Video
Mar-30-19 09:30AM  Why Is Endo (ENDP) Down 26.9% Since Last Earnings Report? Zacks
Mar-27-19 09:11PM  Endo International plc Announces Early Tender Results of its Previously Announced Cash Tender Offers and Consent Solicitations for up to $1.5 billion Aggregate Purchase Price of its Outstanding Senior Notes PR Newswire
Mar-19-19 02:26PM  Catalyst (CPRX) Reports Wider Q4 Loss, Focuses on Firdapse Zacks
07:30AM  Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery PR Newswire
Mar-15-19 10:23AM  BioDelivery (BDSI) Q4 Earnings In Line, Sales Beat, Stock Up Zacks
Mar-14-19 08:06PM  Endo International plc Announces Pricing of Private Offering Of Senior Secured Notes PR Newswire
08:06PM  Endo International plc Announces an Upsizing of its Cash Tender Offers and Consent Solicitations PR Newswire
12:01PM  Endo Finance Co. -- Moody's downgrades Endo's secured debt to Ba3, unsecured notes to Caa1; B2 CFR affirmed Moody's
11:01AM  Insys Plunges on Auditor's Concern About Insufficient Funds Zacks
07:54AM  Endo International plc Announces Debt Refinancing Transactions, Including Cash Tender Offers and Consent Solicitations for up to $1.0 billion Aggregate Purchase Price of its Outstanding Senior Notes PR Newswire
07:51AM  Endo International plc Announces Proposed Private Offering Of Senior Secured Notes PR Newswire
Mar-12-19 09:35AM  Is Endo International (ENDP) a Great Stock for Value Investors? Zacks
Mar-11-19 01:13PM  Opioid litigation concerns weigh on pharmaceutical loan borrowers Reuters
Mar-08-19 08:56AM  Endo (ENDP) Soars: Stock Adds 6% in Session Zacks
06:00AM  State Pensions Fought Guns and Tobacco. Why Arent They Divesting From Opioids? Bloomberg
Mar-07-19 07:35AM  Report: Exploring Fundamental Drivers Behind Procter & Gamble, Consolidated Edison, Lennar, Endo International plc, Box, and FRONT YARD RESIDENTIAL CORP New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire +5.96%
Mar-05-19 04:36PM  What's in Store for BioSpecifics (BSTC) This Earnings Season? Zacks -6.54%
11:12AM  FDA ruling on compounding goes Endo's way American City Business Journals
Mar-04-19 12:45PM  Endo International plc (NASDAQ:ENDP) Insiders Have Been Selling Simply Wall St. -16.99%
08:39AM  Implied Volatility Surging for Endo (ENDP) Stock Options Zacks
08:00AM  Endo to Participate at Cowen & Company 39th Annual Healthcare Conference PR Newswire
Mar-01-19 06:04PM  Endo gains on favorable FDA drug compounding decision Reuters
03:27PM  Endo Announces FDA Decision Not to Include Vasopressin on 503B Bulks List PR Newswire
02:20PM  Endo (ENDP) Q4 Earnings & Revenues Beat Estimates, Shares Up Zacks
07:30AM  Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual Meeting PR Newswire
06:46AM  Edited Transcript of ENDP earnings conference call or presentation 28-Feb-19 12:30pm GMT Thomson Reuters StreetEvents
Feb-28-19 11:42AM  Endo International plc (ENDP) Q4 2018 Earnings Conference Call Transcript Motley Fool +6.29%
06:30AM  Endo Reports Fourth-Quarter And Full Year 2018 Financial Results PR Newswire
Feb-27-19 05:15PM  Endo Announces Termination of Acquisition Agreements with Somerset Therapeutics and Business of Affiliate Wintac Limited PR Newswire
Feb-22-19 07:30AM  Paladin Labs Inc. Announces Approval of Envarsus PA (tacrolimus prolonged-release tablets) in Canada CNW Group
Feb-21-19 10:31AM  Earnings Preview: Endo International (ENDP) Q4 Earnings Expected to Decline Zacks
Feb-07-19 12:59PM  FDA files motion to delay Endo litigation, again American City Business Journals
08:00AM  Endo Agrees Not To Oppose Additional Stay of FDA Litigation Following Restoration of Government Appropriations PR Newswire
Jan-28-19 08:00AM  Today's Research Reports on Trending Tickers: OPKO Health and Endo International ACCESSWIRE
Jan-25-19 05:22PM  Endo to Announce Fourth-Quarter and Full-Year 2018 Financial Results PR Newswire
Jan-08-19 11:34AM  Albany region cities sue pharmaceutical companies over opioid epidemic American City Business Journals
Jan-02-19 11:25AM  Government shutdown puts Endo-FDA lawsuit in limbo American City Business Journals +5.62%
06:58AM  Heron Gains on Priority Review Designation for Pain Drug Zacks
Dec-31-18 08:52AM  Options Traders Expect Huge Moves in Endo (ENDP) Stock Zacks
07:30AM  Endo Announces Anticipated Further Stay of Compounding Litigation Due to Lapse of Government Appropriations PR Newswire
Dec-19-18 07:30AM  Endo to Participate at J.P. Morgan Healthcare Conference PR Newswire -5.11%
Dec-18-18 11:40AM  Catalyst Pharmaceuticals Announces Definitive Agreement with Endo for Vigabatrin Tablets GlobeNewswire
Dec-16-18 07:10AM  Do Hedge Funds Love Endo International plc (ENDP)? Miller Value offer its opinion Insider Monkey
Dec-14-18 05:01PM  Endo International Drops Ahead Of '60 Minutes' Opioid Segment Benzinga -8.53%
03:55PM  Endo International plc (ENDP) Investigated For Violations of Federal Securities Laws by Block & Leviton LLP ACCESSWIRE
03:20PM  Endo International shares fall 8 percent on report of 'shocking' data on opioid distribution CNBC
Dec-12-18 07:54AM  FDA declines to approve Mallinckrodt's abuse-deterrent opioid painkiller Reuters
Dec-11-18 09:23AM  Generic Drugmakers Down on Allegations of Price Fixing Zacks
Dec-08-18 09:30AM  Why Is Endo (ENDP) Down 12.3% Since Last Earnings Report? Zacks
Dec-05-18 02:17AM  Edited Transcript of ENDP earnings conference call or presentation 8-Nov-18 1:00pm GMT Thomson Reuters StreetEvents
Dec-04-18 08:30AM  Factors of Influence in 2018, Key Indicators and Opportunity within Crocs, Ericsson, AAC, Coty, Tutor Perini, and Endo International plc New Research Emphasizes Economic Growth GlobeNewswire
Nov-28-18 04:34PM  Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference PR Newswire
Endo International plc manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. Its U.S. Branded - Specialty & Established Pharmaceuticals segment provides branded prescription products to treat and manage conditions in urology, urologic oncology, endocrinology, pain, and orthopedics. This segment offers XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL Nasal Spray to treat vitamin B12 deficiency; TESTOPEL for TRT in conditions associated with a deficiency or absence of endogenous testosterone; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; VOLTAREN Gel for the relief of joint pain of osteoarthritis; LIDODERM for the relief of pain; FORTESTA Gel for men suffering from hypogonadism; EDEX to treat erectile dysfunction; and TESTIM for TRT in conditions associated with a deficiency or absence of endogenous testosterone. The company's U.S. Branded - Sterile Injectables segment offers branded sterile injectable products, such as VASOSTRICT, ADRENALIN, and APLISOL; and generic sterile injectable products. Its U.S. Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics, and sprays; and products for the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, and oncology. It sells its branded pharmaceuticals and generics directly to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. The company was founded in 1920 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIMMEL ROGER HDirectorJun 17Sale3.9310,00039,300110,000Jun 19 04:01 PM
KIMMEL ROGER HDirectorJun 17Sale3.9324,95198,057148,309Jun 19 04:01 PM
MONTAGUE WILLIAM PDirectorDec 10Sale11.4110,000114,10064,888Dec 10 04:07 PM
Hutson Nancy JDirectorNov 15Sale12.8310,000128,30049,970Nov 16 04:03 PM
KIMMEL ROGER HDirectorAug 14Sale15.9014,000222,600120,000Aug 15 04:22 PM
KIMMEL ROGER HDirectorAug 14Sale15.9012,074191,977145,277Aug 15 04:22 PM